Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Pasithea Therapeutics Corp. (KTTA)

NASDAQ

$0.50

$--

(0.00%)

Pre-Market

Pasithea Therapeutics Corp. (KTTA) Live Price Chart

Last updated: ⁦2026-09-16 12:38:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Pasithea Therapeutics Corp. (KTTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.50, with a market capitalisation of $17.04M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.28 to $2.06. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.04M
Open	$0.50
Day's High	$170.00
Day's Low	$0.28
Previous Close	$0.50
Volume	4.14K
Average Volume	701.91K
P/E Ratio	--
52-Week High	$2.06
52-Week Low	$0.28
Dividend Yield	--
Earnings Date	--

Pasithea Therapeutics Corp. (KTTA) Pre-Market Stock Price

Pasithea Therapeutics Corp. (KTTA) is trading at $0.50 in pre-market trading as of 2026-09-16 12:26:00, unchanged from the previous close of $0.50

Pre-market trading shows how investors are pricing KTTA before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

Pasithea Therapeutics Corp. (KTTA) 7-Day Stock Price Change

Over the past seven days, Pasithea Therapeutics Corp. (KTTA) moved from $0.58 to $0.50, representing a decline of 13.79% ($0.08).

The stock traded between $0.49 and $0.60 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 215.17 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

KTTA 52-Week Price Position

Position in Range: 12.3%

52W Low$0.28

52W High$2.06

KTTA is currently trading at $0.50, placing it 12.3% of the way from its 52-week low of $0.28 to its 52-week high of $2.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pasithea Therapeutics Corp. (KTTA)?

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Pasithea Therapeutics Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.pasithea.com

How to Buy Pasithea Therapeutics Corp. (KTTA) Stock on MEXC

Eligible investors can buy real shares of Pasithea Therapeutics Corp. (KTTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KTTA and Place Your Order

Open the RealStocks trading page and search for KTTA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pasithea Therapeutics Corp. (KTTA) stock price today?

Pasithea Therapeutics Corp. (KTTA) is currently trading at $ 0.50, unchanged from the previous close of $ 0.50. Intraday prices update in real time during regular trading hours.

2.Is KTTA stock going up or down today?

As of 2026-09-16 12:26:00, KTTA is trading at $ 0.50, unchanged from its previous close of $ 0.50. The stock has traded between $ 0.28 and $ 170.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is KTTA pre-market price?

As of 2026-09-16 12:26:00, KTTA is trading at $ 0.50 in pre-market trading, unchanged from the previous close of $ 0.50. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KTTA after-hours price?

As of 2026-09-16 12:26:00, KTTA is trading at $ 0.50 in after-hours trading, unchanged from the regular-session close of $ 0.50. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KTTA stock trading now?

KTTA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KTTA sit relative to its 52-week high and low?

Over the past 52 weeks, KTTA has traded between a low of $ 0.28 and a high of $ 2.06. At $ 0.50, the stock is positioned 12.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pasithea Therapeutics Corp. in?

Pasithea Therapeutics Corp. (KTTA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pasithea Therapeutics Corp.'s market capitalisation and where is it listed?

Pasithea Therapeutics Corp. is listed on the NASDAQ exchange with a market capitalisation of $ 17.04M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KTTA valued in terms of P/E ratio and EPS?

KTTA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.64. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pasithea Therapeutics Corp. pay a dividend?

Pasithea Therapeutics Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.